Sinogen Pharmaceutical has been selected as a "Future Unicorn" innovative enterprise in Guangzhou for 3 consecutive years

At the opening ceremony of the Convention on Exchange of Overseas Talents and Guangzhou Convention of Overseas Chinese Scholars in Science and Technology (OCS) on December 24, 2024, the Guangzhou Association of Science and Technology Innovation Enterprises released the list of "Unicorn" innovative enterprises, "Future Unicorn" innovative enterprises, and "Seed Unicorn" enterprises for 2024. Sinogen Pharmaceutical was selected for the third time as one of the "Future Unicorn" innovative enterprises. 

It is reported that the 2024 Guangzhou "Unicorn” Innovation Enterprise selection was guided by the Guangzhou Science and Technology Bureau, solicited by the Guangzhou Science and Technology Innovation Enterprise Association, and jointly released by the Guangzhou Industrial Development Research Institute and the Guangzhou Science and Technology Innovation Enterprise Association. A total of 200 enterprises were selected for the 2024 "Unicorn" Innovation Enterprise, "Future Unicorn" Innovation Enterprise, and "Seed Unicorn" Enterprise lists.

Enterprises are the main body of technological innovation, and “Unicorn” enterprises are the vanguard force of technological innovation. The Guangzhou “Unicorn” Innovation Enterprise List mainly targets the fields of biomedicine, information technology, artificial intelligence, advanced manufacturing, etc. It aims to discover a group of innovative, fast-growing, and promising innovation enterprises in Guangzhou, accelerate the cultivation and development of productivity, strengthen new driving forces, new ways, and new engines of economic development, and focus on promoting the high-quality development of Guangzhou's new economy and building a modern industrial system.

<END>